Large-Joint Reconstructive Implants – Market Insights – United States

The large-joint reconstructive implant market is driven by a rising older population and a more active younger population in the US. The shift of procedures to the ASC and outpatient settings will place downward pressure on ASPs, however, this trend will also make procedures less expensive and more accessible for patients, driving procedure volume and overall market growth. In addition, the uptake of novel technologies such as patient-conforming and 3-D printed implants, smart implants, robotic- and navigation-assisted surgeries, and minimally invasive techniques will drive growth for the market.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for large-joint reconstructive implants in the US from 2019 through 2034.

The shift of procedures to outpatient and ASC settings and new bundled payment models will force manufacturers to adapt.

How is the shift of procedures to the ASC setting shaping innovation?

How is the use of minimally invasive approaches impacting the site of service shift?

Which procedures are driving the shift to outpatient settings?

How are companies tailoring their strategies to cater to the needs of hospital outpatient departments and ASCs?

Which products are being developed to enable shorter surgery and recovery times in outpatient settings?

Personalization and innovation will help smaller manufacturers compete with the dominant orthopedic companies.

What strategies are being adopted by large manufacturers to compete and improve their shares in the US market?

How are smaller competitors maintaining their presence in the market?

How is merger & acquisition activity impacting market share?

Which technologies, novel approaches and materials are manufacturers focusing on?

Orthopedic surgical robots and AI-enhanced digital services will have a significant impact on the US large-joint reconstructive implant market.

What has driven the recent innovations in robotics from major competitors in the large-joint reconstructive implant space?

Who are the new entrants into the robot-assisted market?

How are companies changing their product mix in response to trends surrounding robotic assistance, navigation technologies, and personalized implants?

How is the adoption of robotic surgery systems and related ecosystems impacting the market and practice within the OR?

What new software and analytics capabilities are manufacturers adding to their service offerings?